The two meta-analysis are interesting, I think. https://www.liebertpub.com/doi/abs/10.1089/thy.2023.0530 https://www.liebertpub.com/doi/abs/10.1089/thy.2023.05

The two meta-analysis are interesting, I think. https://www.liebertpub.com/doi/abs/10.1089/thy.2023.0530 https://www.liebertpub.com/doi/abs/10.1089/thy.2023.0530 > Overall there is no conclusive evidence of elevated thyroid cancer risk. https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.15382 https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/do... > Our meta-analysis showed that GLP-1RA treatment could be associated with a moderate increase in relative risk for thyroid cancer in clinical trials, with a small increase in absolute risk. Studies of longer duration are required to assess the clinical implications of this finding. It's potentially a possibility, but the absolute risk seems to still be quite low.